Shineco launched the world's first on-chain cell asset tokenization platform, partnering with Plus Me Limited to tokenize stem cell assets on Ethereum. The company acquired a 51% stake in Xi'an Dong'ao Health Management to support its blockchain and biotechnology infrastructure.

Shineco will implement a 50:1 reverse stock split effective August 11, 2025, to address Nasdaq's minimum bid price requirement. The split will reduce outstanding shares from approximately 45,722,728 to 914,455, with the stock continuing to trade under the symbol 'SISI'.

Shineco, Inc. announced the closing of its underwritten public offering of 1,869,160 shares of common stock at a price of $1.07 per share, raising approximately $2 million in gross proceeds. The company also granted the underwriters an option to purchase up to an additional 280,374 shares.

The S&P 500 index rose over 1% on Friday, with Citigroup reporting better-than-expected Q2 results. Vicinity Motor, Nisun International, and Zapp Electric Vehicles saw significant stock price increases, while Shineco and Kazia Therapeutics experienced declines.

The Nasdaq Composite gained around 1% on Friday, with JPMorgan Chase reporting better-than-expected second-quarter earnings. Several other companies also saw significant stock movements.